GlassScriptPhysician profile
Daniel H Lamont
NPI 1407948847
$24,719.10
in general payments reported to CMS, 2019-2025
55 companies · $3,813 in 2025
The $3,813 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,608 · 2020: $2,360 · 2021: $2,599 · 2022: $3,712 · 2023: $3,719 · 2024: $2,908 · 2025: $3,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,440.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,812.00 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,952.12 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Vigilant X4 Crt-D |
| Amgen INC. | $1,844.73 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,681.10 | 2019-2025 | |
| Penumbra, INC. | $1,276.53 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $902.18 | 2019-2025 | Lifevest |
| Abbott Laboratories | $869.61 | 2019-2025 | Xience Skypoint, Jot Dx, Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $846.03 | 2019-2025 | Camzyos, Eliquis |
| Sanofi-Aventis U.S. LLC | $804.39 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $801.97 | 2019-2025 | Jardiance |
| Pfizer INC. | $791.54 | 2019-2025 | |
| Inari Medical, INC. | $755.18 | 2022-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Impulse Dynamics (USA) INC. | $698.58 | 2022-2023 | Optimizer |
| Shockwave Medical, INC | $604.43 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $594.02 | 2022-2025 | Amvuttra |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $560.52 | 2019-2024 | Xarelto |
| Aop Health US, LLC | $525.00 | 2025 | Rapiblyk |
| Regeneron Healthcare Solutions, INC. | $494.18 | 2019-2022 | |
| Stryker Corporation | $456.80 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $412.99 | 2021-2025 | Corevalve Evolut R, Micra, Linq II |
| Merck Sharp & Dohme LLC | $408.47 | 2021-2025 | Verquvo, Winrevair |
| Scpharmaceuticals INC. | $398.27 | 2023-2025 | |
| Medtronic Vascular, INC. | $369.03 | 2019-2020 | |
| Esperion Therapeutics, INC. | $347.53 | 2020-2024 | Nexletol |
| Novo Nordisk INC | $344.05 | 2022-2025 | Ozempic, Wegovy |
| Cvrx, INC. | $315.61 | 2020-2025 | Barostim Neo System |
| Chiesi USA, INC. | $259.15 | 2019-2022 | |
| Abiomed | $254.35 | 2019-2025 | Impella |
| Kestra Medical Technology Services, INC. | $253.79 | 2022-2025 | Assure Wcd |
| Amarin Pharma, INC. | $215.53 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $199.88 | 2023-2025 | |
| Astellas Pharma US INC | $191.89 | 2019-2022 | |
| Infobionic, INC | $166.85 | 2025 | Mome Device |
| Astrazeneca Pharmaceuticals LP | $147.33 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $128.85 | 2021-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $111.67 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $102.64 | 2024-2025 | Uptravi, Opsumit |
| Tactile Systems Technology INC | $100.65 | 2020-2022 | |
| Cardiva Medical, INC. | $98.49 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire, Cardiva Vascade 6/7f Vcs |
| Cardiovascular Systems INC. | $95.33 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $68.10 | 2020-2022 | |
| Bridgebio Pharma, INC. | $50.00 | 2025 | Attruby |
| Otsuka America Pharmaceutical, INC. | $49.49 | 2019 | |
| Atricure, INC. | $46.63 | 2022-2025 | Atriclip Laa Exclusion System |
| Azurity Pharmaceuticals, INC. | $41.34 | 2023 | Edarbi |
| Gilead Sciences, INC. | $37.37 | 2019 | |
| Bardy Diagnostics, INC. | $37.33 | 2020-2021 | |
| Edwards Lifesciences Corporation | $33.82 | 2019 | |
| Preventice Services, LLC | $31.93 | 2021 | |
| Philips North America LLC | $28.22 | 2024-2025 | (Bs2) Lm Undivided, Ice 3d |
| Cleerly, INC. | $27.82 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Celgene Corporation | $24.06 | 2023 | Camzyos |
| Altathera Pharmaceuticals LLC | $21.90 | 2025 | Sotalol Hydrochloride |
| Lundbeck LLC | $14.26 | 2020 | |
| Itamar Medical INC | $13.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lamont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.